查看完整行情页>>

|

货币单位:美元(USD)

INVO BioScience, Inc. (invo)

实时(?):
盘后(?):
读取中...
  • -- (--%)
开盘价:-- 最高价:-- 最低价:-- 52周最高价:-- 52周最低价:--
成交量:-- 平均成交量:-- 市值:-- 市盈率:-- 预期市盈率:--
每股收益:-- 贝塔系数:-- 股息:-- 收益率:-- 总股本:--
Steven M. Shum Steven M. Shum is the founder of Revere Data LLC, which was founded in 2000. He held the title of Executive Vice President from 2000 to 2004. Mr. Shum's current job(s) include Chief Executive Officer & Director at INVO BioScience, Inc. since 2019, Independent Director at CalEthos, Inc. since 2021, Independent Director at Expion360, Inc. since 2022, and Managing Principal at Core Fund Management LP since 2007. He is also a Fund Manager at Core Fund LP since 2004. Mr. Shum's former job(s) include Chief Operating Officer, Secretary & Director at XZERES Corp. from 2008 to 2015, Portfolio Manager at DNB Capital Management, Inc. from 1994 to 2000, and Secretary, Chief Financial & Accounting Officer at Eastside Distilling, Inc. in 2019. Mr. Shum obtained his undergraduate degree from Portland State University in 1992.
J. Chris Jensen J. Chris Jensen is currently the Vice President-Engineering & Regulatory Affairs at INVO BioScience, Inc. Previously, he worked as the Senior Director-Regulatory Affairs & Compliance at CooperSurgical, Inc. He completed his undergraduate and graduate degrees at Rutgers University-New Brunswick.
Inger Britt Carlsson Inger Britt Carlsson is currently the Vice President-Medical Affairs at INVO BioScience, Inc. She received a doctorate degree from Karolinska Institutet in 2008 and an undergraduate degree from California Polytechnic State University (San Luis Obispo).
Michael J. Campbell Michael J. Campbell's current job is as the Chief Operating Officer & VP-Business Development at INVO BioScience, Inc. Mr. Campbell's former jobs include being the Vice President-International Business Unit at CooperSurgical, Inc. from 2013 to 2014, and being the VP-Sales, Marketing & Business Development at 40 J's LLC from 1997 to 2006. Additionally, he held the position of VP-Sales, Marketing & Business Development at Retroactive Bioscience from 1997 to 2006. Mr. Campbell obtained his undergraduate degree from Fitchburg State University in 1980.
Andrea Goren Andrea Goren is currently the Director at iSign Solutions, Inc. and Treasurer & Director at Ben-Gurion University of the Negev. He is also the Manager at SG Phoenix Ventures LLC and the Chief Financial Officer at INVO BioScience, Inc. Additionally, he serves as the Managing Member at Andax LLC. In his former positions, Mr. Goren worked as the Director at The Fairchild Corp. from 2008 to 2010 and as the Director at Xplore Technologies Corp. from 2004 to 2018. He also held the role of Chief Financial Officer & Managing Director at SG Phoenix LLC from 2003 to 2021. Furthermore, he was the Chief Financial Officer & Managing Director at Phoenix Fulfillment Group Ltd. and the Manager at Phoenix Venture Fund LLC. Prior to that, he served as the Vice President at Shamrock International Corp. from 1999 to 2002. Mr. Goren completed his undergraduate degree at Connecticut College in 1989. He later obtained an MBA from Columbia Business School in 1994.
Matthew K. Szot Matthew K. Szot is the founder and currently holds the position of Chief Financial Officer at Cadrenal Therapeutics, Inc., which was founded in 2022. He is also currently serving as Vice Chairman at SenesTech, Inc. since 2015, Independent Director at INVO BioScience, Inc. since 2020, Director at S&W Seed Co. Australia Pty Ltd., Director at S&W Holdings Australia Pty Ltd., Chief Financial Officer at Boustead Securities LLC, Chief Financial Officer at Strands Management Co. LLC since 2007, Manager at Seed Holding LLC, and Manager at Stevia California LLC. In his former positions, Mr. Szot served as Director at Secure America Acquisition Corp., Director at Eastside Distilling, Inc. from 2018 to 2019, Chief Financial Officer at Monarch Staffing, Inc., Chief Financial Officer, Secretary & Treasurer at Pinnacle Energy Corp. from 2009 to 2010, Chief Financial Officer at Quantum Information, Inc., Chief Financial Officer at Mobivity Holdings Corp. in 2011, Audit Manager at KPMG LLP from 1996 to 2003, Treasurer at Lathian Systems, Inc., Chief Financial, Accounting Officer & Secretary at MMEX Resources Corp. from 2009 to 2010, CFO, CAO, Senior VP & Head-Investor Relations at S&W Seed Co. from 2010 to 2021, Chief Financial Officer & Secretary at Rip Curl, Inc. from 2003 to 2006, Chief Financial Officer at Trans-Pacific Aerospace Co., Inc. from 2009 to 2010, and Chief Financial Officer at Cardiff Partners LLC from 2007 to 2011. Mr. Szot obtained his undergraduate degree from the University of Illinois At Urbana–Champaign in 1996.
Rebecca Messina Rebecca Messina is currently the Director at Make-A-Wish Foundation of America, Director at The Advertising Council, Inc., Independent Director at INVO BioScience, Inc., Director at Mobile Marketing Association, Inc., Independent Director at SOS Hydration, Inc., Director at ZICO Rising, Inc., Member Board of Directors at Luthman Backlund Foods Europe AB, Senior Advisor at McKinsey & Co., Inc., CMO Advisory Board at Ridge Ventures, Operating Advisor at Groundforce Capital Management, LLC, and Advisor at Jove Island Capital GP LLC. She previously worked as the Director at Outdoor Voices, Inc., Vive Organic, Inc., and Archer Roose, Inc. She was also the Chief Marketing Officer & Senior Vice President at Beam Suntory, Inc. and Senior Vice President-Marketing & Innovation at The Coca-Cola Co. She has an undergraduate degree from Miami University.
Barbara Ann Ryan Barbara Ann Ryan is the founder of Fabulous Pharma Females, Inc. (founded in 2010) and Barbara Ryan Advisors LLC (founded in 2012), where she holds the title of Chief Executive Officer. Currently, Ms. Ryan holds multiple positions, including Director at Safecor Health LLC, Independent Non-Executive Director at Indivior PLC, Independent Director at INVO BioScience, Inc., Director at Ocuterra Therapeutics, Inc., Independent Director at Azitra, Inc., Independent Director at MiNK Therapeutics, Inc., Director at Gilda’s Club New York City, Partner, Head-Healthcare & Life Sciences at Clermont Partners LLC, and Investor Relations Contact at Rafael Holdings, Inc. In the past, Ms. Ryan worked as a Managing Director-Strategic Communications at FTI Consulting, Inc. from 2013 to 2014, Managing Director at Deutsche Bank Securities, Inc. from 1999 to 2012, Research Analyst at Prudential Securities, and held positions at Radius Health, Inc. and Alex. Brown & Sons, Inc. Ms. Ryan's education includes an undergraduate degree from the State University of New York at Buffalo and the University of Massachusetts.
Trent Donald Davis Trent Donald Davis is currently the Chief Executive Officer at Paulson Investment Co. LLC. He also holds the position of Chief Executive Officer at Paulson Investment Co. LLC (Broker), Chief Executive Officer at Paulson Capital Holding Co. LLC, and Independent Director at INVO BioScience, Inc. Additionally, he serves as an Independent Director at Senmiao Technology Ltd. In the past, Mr. Davis has held positions such as Chairman at RegenETP, Inc., Chairman at Majesco Entertainment Co., and Chairman at The National Investment Banking Association. He has also served as Vice Chairman at Eastside Distilling, Inc., Lead Independent Director at Dataram Corp., President & Director at Paulson Capital (Delaware) Corp., President, Chief Operating Officer & Director at Whitestone Investment Network, Inc., and Director at BioCurex, Inc. Furthermore, he has been a Non-Independent Director at VBI Vaccines, Inc.Mr. Davis completed his undergraduate degree at Linfield College in 1990. He later obtained an MBA from the University of Portland in 1995.